Search
Now showing items 1-8 of 8
Antibacterial activity of rationally designed antimicrobial peptides.
(Hindawi, 2020)
Many infectious diseases are still prevalent in the world’s populations since no effective treatments are available to eradicate them.
e reasons may either be the antibiotic resistance towards the available therapeutic ...
Dietary effects of antimicrobial peptides in therapeutics
(Taylor & Francis, 2020-02-17)
The notable increase in drug-resistant infections and the failure of the most potent antibiotics to establish their curative effect without side effect have presented a serious need for the discovery of new therapeutic ...
Identification of biomarkers for the accurate and sensitive diagnosis of three bacterial pneumonia pathogens using in silico approaches
(Springer Nature, 2020)
: Pneumonia ranks as one of the main infectious sources of mortality among kids under 5 years of age,
killing 2500 a day; late research has additionally demonstrated that mortality is higher in the elderly. A few ...
Diagnostic approaches of pneumonia for commercial-scale biomedical applications: An overview
(Taylor & Francis, 2020)
Pneumonia remains the leading infectious cause of death among children under five years of age,
and the elderly. Several biomarkers, which have been identified for its diagnosis lack specificity, as
they could not ...
Nanotechnology-based delivery systems for antimicrobial peptides
(MDPI, 2021)
Antimicrobial resistance (AMR) is a significant threat to global health. The conventional antibiotic pool has been depleted, forcing the investigation of novel and alternative antimicrobial strategies. Antimicrobial peptides ...
Analytical studies of antimicrobial peptides as diagnostic biomarkers for the detection of bacterial and viral Pneumonia
(MDPI, 2022)
Pneumonia remains one of the leading causes of infectious mortality and significant
economic losses among our growing population. The lack of specific biomarkers for correct and timely
diagnosis to detect patients’ status ...
Acyldepsipeptide analogues: A future generation antibiotics for Tuberculosis treatment
(MDPI, 2022)
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs),
which are currently explored for treatment of pathogenic infections, including tuberculosis (TB).
These cyclic hydrophobic peptides ...
Design and synthesis of acyldepsipeptide-1 analogues: antibacterial activity and cytotoxicity screening
(Arabian Journal of Chemistry, 2023)
Acyldepsipeptides (ADEPs) are receiving more attention as prospective antimicrobial agents due to their unique mode of action and chemical properties. However, their therapeutic potential is limited by their poor pharmacokinetic ...